Neoadjuvant chemoradiotherapy changes the landscape of soluble immune checkpoint molecules in patients with locally advanced rectal cancer

HIGHLIGHTS

• who: Chao Liu from the The University of Hong, Hong SAR, China have published the research work: Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer, in the Journal: (JOURNAL)
• what: The study described for the first time the changes of soluble immune checkpoint molecules (sPD-L1, sCD80, sCD86, sCD28, sGITR, sGITRL, sCD27, and sICOS) in patients with LARC following radiotherapy.
• how: All statistical data were analyzed with R (http//www.r-project.org) SPSS 24.0 and the GraphPad 5.0 software. In this . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.